Global Financial Crisis Could Speed Up Sending Pharma Research To China
This article was originally published in PharmAsia News
Executive Summary
BEIJING - The financial crisis ricocheting across the United States and Europe could cut into R&D funding by the globe's top pharmaceutical powers, but is also likely to trigger sending more drug research to Chinese scientists, according to industry insiders and analysts
You may also be interested in...
PPD Continues High-speed Expansion In Asia With Second Acquisition Of A China-based CRO This Quarter
BEIJING - As part of a rapid-fire expansion across Asia, the U.S.-headquartered PPD has outlined plans to purchase and merge with the Beijing-based contract research organization BioDuro
PPD Continues High-speed Expansion In Asia With Second Acquisition Of A China-based CRO This Quarter
BEIJING - As part of a rapid-fire expansion across Asia, the U.S.-headquartered PPD has outlined plans to purchase and merge with the Beijing-based contract research organization BioDuro
PPD Continues High-speed Expansion In Asia
U.S.-based CRO makes its second acquisition this quarter of a Chinese CRO.